As of Sep 30, 2024, Prestige Consumer Healthcare Inc.'s fair value using the Ben Graham formula is $68.8 per share. This is calculated using Ben Graham formula, where EPS is $4.1 and BVPS (Book Value Per Share) is $34.7. The current price of $75.3 suggests Prestige Consumer Healthcare Inc. may be overvalued by this conservative metric.
Prestige Consumer Healthcare Inc. earnings per share (EPS) for the twelve months ending Sep 30, 2024, was $4.1, a 5.4% growth year-over-year.
Prestige Consumer Healthcare Inc.'s margin of safety is negative 8.6%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.